Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Non-Selective Beta-Adrenergic Blocker in Severe Traumatic Brain Injury

NCT06870370 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06870370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06870370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Non-Selective Beta-Adrenergic Blocker in Severe Traumatic Brain Injury
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 20, 2025
Completion date
September 20, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care unit, intracranial pressure, mortality, traumatic brain injury (tbi) patients